Ausschreibungen Universitätsprofessuren

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its profile-forming research foci in neuroscience, cardiovascular medicine, and oncology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies, a

W2 professorship (tenured)

(f/m/d)

Translational Otology

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

We are looking for a highly qualified, internationally visible scientist with an independent scientific profile as well as comprehensive knowledge and many years of experience in the field of ear, nose and throat medicine that qualify you to take on a clinical management position. Moreover, within the field of experimental otology, a focus on inner ear research will be required. Experience in the fields of animal experiments, basic electrophysiological research, and optical measurements of cellular activity in the auditory and vestibular organs is desirable. The applicant is expected to contribute preclinically in the field of optogenetic applications and to advance the clinical translation of optogenetic hearing rehabilitation in collaboration with the EKFZ teams and platforms. We are looking for a researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists, and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz-NHG). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest: http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de).

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its profile-forming research foci in neuroscience, cardiovascular medicine, and oncology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, the UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions on the site.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) at UMG, a

W2 professorship (tenured)

(f/m/d)

Disease Modelling

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

The position is associated with setting up and leading the Disease Modelling platform of EKFZ in collaboration with the other platforms and teams of EKFZ. We are looking for a highly qualified, internationally visible scientist with an independent scientific profile as well as comprehensive knowledge and many years of experience in the development and characterization of cell- and tissue-based disease models and tools for regenerative medicine. Practical experience in the production of cell and organoid models of human diseases derived from induced pluripotent stem cells, in their molecular and physiological characterization, as well as experience in multidisciplinary cooperation for the application and characterization of disease models in preclinical studies are required. We are looking for a researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest: http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de).

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its profile-forming research foci in neuroscience, cardiovascular medicine, and oncology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies, a

W2 professorship (tenured)

(f/m/d)

Translational Ophthalmology

is to be filled at the earliest possible date.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

We are looking for a highly qualified, internationally visible clinician scientist with an independent scientific profile as well as comprehensive knowledge and many years of experience in retinal dystrophies and/or in the field of gene therapeutic restoration of vision that qualify you to take on a leading clinical and research position. We especially welcome applications of clinician scientists with track in clinical translation. Experience in the fields of animal experiments, basic electrophysiological research, and optical measurements of cellular activity in the retina as well as in the implementation of early clinical trials including diagnostic low vision tests and visual rehabilitation is desirable. The applicant is expected to contribute preclinically in the field of optogenetic applications and to advance the clinical translation of optogenetic vision restoration as part of the Dept. of Ophthalmology and in collaboration with other EKFZ teams and platforms. We are looking for a clinical researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists, and the development of teaching in medicine, biomedicine, and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz - NHG). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome and the holder of the position would be integrated in an international team.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest: http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de).

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.

As part of its strategic planning, the University Medical Center Göttingen (UMG) is pursuing the consistent development of its profile-forming research foci in neuroscience, cardiovascular medicine, and oncology with translational approaches, among others, within the new Else Kröner Fresenius Center for Optogenetic Therapies. On the Göttingen Campus, UMG is closely linked to the natural and life science institutions of the University as well as the non-university institutions.

As part of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) at UMG, a

W2 professorship with tenure track option

(f/m/d)

Opsin Engineering

is to be filled at the earliest possible date. The appointment is initially for a period of five years and will become permanent upon positive tenure evaluation in the fifth year.

The Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ) is a new interdisciplinary clinical research center of the UMG with partners at the Göttingen Campus as well as at Medical University of Hannover, Technical University of Chemnitz, and University of Freiburg. The goal of EKFZ is the development and clinical translation of optogenetic therapies for the deaf and the blind as well as development of optogenetic gastric pacemakers and brain computer interfaces.

The position is associated with setting up and leading the Opsin Engineering platform of EKFZ in collaboration with the other platforms and teams of EKFZ. We are looking for a highly qualified, internationally visible scientist with an independent scientific profile as well as extensive knowledge and many years of experience in the development of molecular optogenetic tools (opsins), their biophysical characterization and preparation of their use for biomedical applications, in particular future optogenetic therapies. Practical experience in the rational design of new opsin variants, the bioinformatic analysis of candidate genes and high-throughput characterization of opsin variants, as well as experience with multidisciplinary cooperation for the application and characterization of the developed opsins in preclinical studies are required. We are looking for a researcher who will pursue further methodological development through collaborative use of the infrastructure available at the Göttingen Campus and make a substantial contribution to the acquisition of competitive third-party funding, the promotion of young scientists and the development of teaching in biomedicine and life sciences. An interdisciplinary research environment provided by the participating institutions of the EKFZ is guaranteed.

A habilitation or an equivalent scientific qualification is required, as well as teaching experience. Further requirements for the appointment of university professors are laid out in the current version of § 25 of the Higher Education Act of the State of Lower Saxony (Niedersächsisches Hochschulgesetz). The UMG reserves the right of appointment.

Applications from scientists from abroad are explicitly welcome.

UMG aims to increase the proportion of women and therefore explicitly invites qualified women to apply. Severely disabled persons will be given preferential consideration if they have the same qualifications.

Please submit your application documents online via the following link by 31.08.2024 at the latest: http://go.umg.eu/berufungen

For further information on the research profile of the EKFZ, please contact Dr. Tobias Moser (designated EKFZ spokesperson, tmoser(at)gwdg.de).

If you have any questions, please do not hesitate to contact us at Berufungen(at)med.uni-goettingen.de.